AHPA adopts Guidance Policy on supplements and foods containing hemp and hemp-derived CBD

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe >>

View recent alerts:

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

AHPA adopts Guidance Policy on supplements and foods containing hemp and hemp-derived CBD

Supplements or foods that contain hemp or CBD should be manufactured in compliance with applicable federal regulations

Published: Thursday, March 28, 2019

The American Herbal Products Association (AHPA) has adopted a new Guidance Policy for dietary supplement and food products that contain hemp and hemp-derived cannabidiol (CBD) to help ensure the industry complies with existing regulations.

The guidance policy was developed to encourage industry to be mindful of the federal regulations that apply to these product categories, notwithstanding FDA’s ongoing review of the status of CBD and potential pathways for lawful addition of CBD to food and dietary supplements.

"FDA’s current position on the lawful status of CBD shouldn't be misinterpreted to mean that FDA does not regulate supplement or food products that contain hemp or CBD," said AHPA President Michael McGuffin. "Hemp and CBD companies should maintain compliance with established regulations for dietary supplement and food products to ensure quality and safety."

The policy recommends that any manufacturer, labeler, packer, holder or marketer of dietary supplements or foods that contain hemp or CBD comply with the following federal regulations:

  • food facility registration;
  • current good manufacturing and good agricultural practice regulations;
  • labeling requirements, including nutrition labeling, allergen disclosure, listing of required contact information, absence of drug claims, etc.;
  • new dietary ingredient and food additive provisions, where applicable; and
  • applicable obligations for timely submission to FDA of any received serious adverse event reports associated with their products;

AHPA develops guidance policies to promote responsible commerce in herbal supplements by addressing a variety of labeling and manufacturing issues. These policies reflect the consensus of AHPA members and Board of Trustees. AHPA encourages its members and non-member companies to adopt these policies to establish consistent and informed trade practices.

Print

More links

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.